Potent TLR9-Selective and TLR9/7 Dual Antagonists | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Potent TLR9-Selective and TLR9/7 Dual Antagonists

Implementing Organization

Indian Institute of Chemical Engineers

Indian Institute of Chemical Biology (IICB)

About

A series of potent inhibitors of toll-like receptor (TLR) 9 as well as dual antagonists of TLR9 and TLR with potential application in auto-immune disease and metabolic syndrome.

Patent Details

US10662177

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Potent TLR9

Status

completed

Patent No.

US10662177

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :01

Grant :00